TrialInvestigational new drugs2012

A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial.

Tianhong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.